{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antifungal compounds", "Antimicrobial compounds", "Liriodenine", "Medicinal plants", "Paracoccidioidomycosis", "Systemic mycosis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33193751", "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "28"}], "Language": ["eng"], "ELocationID": ["e20200023", "10.1590/1678-9199-JVATITD-2020-0023"], "Journal": {"ISSN": "1678-9199", "JournalIssue": {"Volume": "26", "PubDate": {"Year": "2020", "Month": "Oct", "Day": "28"}}, "Title": "The journal of venomous animals and toxins including tropical diseases", "ISOAbbreviation": "J Venom Anim Toxins Incl Trop Dis"}, "ArticleTitle": "Antifungal activity of liriodenine on agents of systemic mycoses, with emphasis on the genus <i>Paracoccidioides</i>.", "Pagination": {"StartPage": "e20200023", "MedlinePgn": "e20200023"}, "Abstract": {"AbstractText": ["Endemic systemic mycoses remain a health challenge, since these opportunistic diseases are increasingly infecting immunosuppressed patients. The simultaneous use of antifungal compounds and other drugs to treat infectious or non-infectious diseases has led to several interactions and undesirable effects. Thus, new antifungal compounds should be investigated. The present study aimed to evaluate the activity of liriodenine extracted from <i>Annona macroprophyllata</i> on agents of systemic mycoses, with emphasis on the genus <i>Paracoccidioides</i>.", "The minimum inhibitory concentration (MIC) and minimum fungicide concentration (MFC) were determined by the microdilution method. The cellular alterations caused by liriodenine on a standard <i>P. brasiliensis</i> (Pb18) strain were evaluated by transmission and scanning electron microscopy.", "Liriodenine was effective only in 3 of the 8 strains of the genus <i>Paracoccidioides</i> and in the <i>Histoplasma capsulatum</i> strain, in a very low concentration (MIC of 1.95 \u03bcg.mL<sup>-1</sup>); on yeasts of <i>Candida</i> spp. (MIC of 125 to 250 \u03bcg.mL-1), including <i>C. krusei</i> (250 \u03bcg.mL<sup>-1</sup>), which has intrinsic resistance to fluconazole; and in <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> (MIC of 62.5 \u03bcg.mL<sup>-1</sup>). However, liriodenine was not effective against <i>Aspergillus fumigatus</i> at the studied concentrations. Liriodenine exhibited fungicidal activity against all standard strains and clinical isolates that showed to be susceptible by <i>in vitro</i> tests. Electron microscopy revealed cytoplasmic alterations and damage to the cell wall of <i>P. brasiliensis</i> (Pb18).", "Our results indicate that liriodenine is a promising fungicidal compound that should undergo further investigation with some chemical modifications."]}, "AuthorList": [{"Identifier": ["0000-0002-6554-4047"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Tropical Disease and Imaging Diagnosis, Botucatu Medical School, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Vinche", "ForeName": "Adriele Dandara Levorato", "Initials": "ADL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad de Ciencias y Artes de Chiapas, Tuxtla Gutierrez, Chiapas, Mexico."}], "LastName": "de-la-Cruz-Chac\u00f3n", "ForeName": "Iv\u00e1n", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad de Ciencias y Artes de Chiapas, Tuxtla Gutierrez, Chiapas, Mexico."}], "LastName": "Gonz\u00e1lez-Esquinca", "ForeName": "Alma Rosa", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Tropical Disease and Imaging Diagnosis, Botucatu Medical School, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "da Silva", "ForeName": "Julhiany de F\u00e1tima", "Initials": "JF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Ferreira", "ForeName": "Gisela", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Dos Santos", "ForeName": "Daniela Carvalho", "Initials": "DC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biosciences of Botucatu, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Garces", "ForeName": "Hans Garcia", "Initials": "HG"}, {"Identifier": ["0000-0002-0267-3589"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Ci\u00eancias da Sa\u00fade, Universidade do Oeste Paulista (Unoeste), Presidente Prudente, SP, Brazil."}], "LastName": "de Oliveira", "ForeName": "Daniela Vanessa Moris", "Initials": "DVM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Tropical Disease and Imaging Diagnosis, Botucatu Medical School, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Mar\u00e7on", "ForeName": "Camila", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Tropical Disease and Imaging Diagnosis, Botucatu Medical School, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Cavalcante", "ForeName": "Ricardo de Souza", "Initials": "RS"}, {"Identifier": ["0000-0002-0661-5917"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Tropical Disease and Imaging Diagnosis, Botucatu Medical School, S\u00e3o Paulo State University (UNESP), Botucatu, SP, Brazil."}], "LastName": "Mendes", "ForeName": "Rinaldo Poncio", "Initials": "RP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Brazil", "MedlineTA": "J Venom Anim Toxins Incl Trop Dis", "NlmUniqueID": "101201501", "ISSNLinking": "1678-9180"}, "CoiStatement": "Competing interests: The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Mendes RP, Cavalcante RS, Marques SA, Marques MEA, Venturini J, Sylvestre TF, et al. Paracoccidioidomycosis: current perspectives from Brazil. Open Microbiol J. 2017;11:224\u2013282.", "ArticleIdList": ["PMC5695158", "29204222"]}, {"Citation": "Teixeira MM, Theodoro RC, de Carvalho MJ, Fernandes L, Paes HC, Hahn RC, et al. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol Phylogenet Evol. 2009;52(2):273\u2013283.", "ArticleIdList": ["19376249"]}, {"Citation": "Matute DR, McEwen JG, Puccia R, Montes BA, San-Blas G, Bagagli E, et al. Cryptic speciation and recombination in the fungus Paracoccidioides brasiliensis as revealed by gene genealogies. Mol Biol Evol. 2006;23(1):65\u201373.", "ArticleIdList": ["16151188"]}, {"Citation": "Mu\u00f1oz JF, Farrer RA, Desjardins CA, Gallo JE, Sykes S, Sakthikumar S, et al. Genome diversity, recombination, and virulence across the major lineages of Paracoccidioides. mSphere. 2016;1", "ArticleIdList": ["PMC5040785", "27704050"]}, {"Citation": "Turissini DA, Gomez OM, Teixeira MM, McEwen JG, Matute DR. Species boundaries in the human pathogen Paracoccidioides. Fungal Genet Biol. 2017;106:9\u201325.", "ArticleIdList": ["PMC8335726", "28602831"]}, {"Citation": "Mendes RP. Paracoccidioidomycosis surveillance and control. J Venom Anim Toxins incl Trop Dis. 2010;16(2):194\u2013197. doi: 10.1590/S1678-91992010000200003.", "ArticleIdList": ["10.1590/S1678-91992010000200003"]}, {"Citation": "Coutinho ZF, Silva D, Laz\u00e9ra M, Petri V, Oliveira RM, Sabroza PC, et al. Paracoccidioidomycosis mortality in Brazil (1980-1995) Cad Saude Publica. 2002;18(5):1441\u20131454.", "ArticleIdList": ["12244377"]}, {"Citation": "Kamikawa CM, Mendes RP, Vicentini AP. Standardization and validation of Dot-ELISA assay for Paracoccidioides brasiliensis antibody detection. J Venom Anim Toxins incl Trop Dis. 2017;23:11. doi: 10.1186/s40409-017-0101-3.", "ArticleIdList": ["10.1186/s40409-017-0101-3", "PMC5312266", "28239394"]}, {"Citation": "Ribeiro SM, Nunes TF, Cavalcante RS, Paniago AMM, Mendes RP. A scoping study of pulmonary paracoccidioidomycosis: severity classification on radiographic and tomographic evaluation. J Venom Anim Toxins incl Trop Dis. 2020;26:e20200107. doi: 10.1590/1678-9199.", "ArticleIdList": ["10.1590/1678-9199", "PMC9704082", "36465893"]}, {"Citation": "Pereira EF, Gegembauer G, Chang MR, Camargo ZP, Nunes TF, Ribeiro SM, et al. Comparison of clinico-epidemiological features in paracoccidioidomycosis patients regarding serological classification using antigens from Paracoccidioides brasiliensis complex and Paracoccidioides lutzii. PLoS Negl Trop Dis. 2020;14(8):e0008485.", "ArticleIdList": ["PMC7447013", "32841237"]}, {"Citation": "Adenis AA, Aznar C, Couppi\u00e9 P. Histoplasmosis in HIV- infected patients: a review of new developments and remaining gaps. Curr Trop Med Rep. 2014;1(2):119\u2013128.", "ArticleIdList": ["PMC4030124", "24860719"]}, {"Citation": "Uzun O, Ascioglu S, Anaissie EJ, Rex JH. Risk factors and predictors of outcome in patients with cancer and breakthrought candidemia. Clin Infect Dis. 2001;32(12):1713\u20131717.", "ArticleIdList": ["11360213"]}, {"Citation": "Sfadar A, Chatuvedi V, Cross EW, Park S, Bernard EM, Armstrong D, et al. Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother. 2001;45(7):2129\u20132133.", "ArticleIdList": ["PMC90613", "11408236"]}, {"Citation": "Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD. Treatment of cryptococcal meningites associated with the acquired immune deficiency syndrome. N Engl J Med. 1997;337(1):15\u201321.", "ArticleIdList": ["9203426"]}, {"Citation": "Denning DW, Pleurery A, Cole DC. Global burden of chronic pulmonary aspergilosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011;89(12):864\u2013872.", "ArticleIdList": ["PMC3260898", "22271943"]}, {"Citation": "Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/AIDS. Lancet Infect Dis. 2017;17(11):e334\u2013e343.", "ArticleIdList": ["28774701"]}, {"Citation": "Putot A, Perrin S, Jolivet A, Vantilcke V. HIV - associated disseminated histoplasmosis in western French Guiana, 2002-2012. Mycoses. 2015;58(3):160\u2013166.", "ArticleIdList": ["25641000"]}, {"Citation": "Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, et al. High incidences of invasive fungal infections in acute myeloid leukemia patients receiving inductin chemotherapy without systemic antifugal prophylaxis: a prospective observational study in Taiwan. PLoS One. 2015;10(6):e0128410.", "ArticleIdList": ["PMC4462587", "26061179"]}, {"Citation": "Harrison N, Mitterbauer M, Tobudic S, Kalhs P, Rabitsch W, Greinix H, et al. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study. BMC Infect Dis. 2015;15:584.", "ArticleIdList": ["PMC4696168", "26715563"]}, {"Citation": "Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE., Jr Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004;38(9):1279\u20131286.", "ArticleIdList": ["15127341"]}, {"Citation": "Walsh CT, Wencewicz TA. Prospects for new antibiotics: a molecule-centered perspective. J Antibiot (Tokyo) 2014;67(1):7\u201322.", "ArticleIdList": ["23756684"]}, {"Citation": "Sharifi-Rad J, Salehi B, Varoni EM, Sharopov F, Yousaf Z, Ayatollahi SA, et al. Plants of the Melaleuca Genus as antimicrobial agents: from farm to pharmacy. Phytother Res. 2017;31(10):1475\u20131494.", "ArticleIdList": ["28782167"]}, {"Citation": "Ghaderi L, Moghimi R, Aliahmadi A, McClements DJ, Rafati H. Development of antimicrobial nanoemulsion-based delivery systems against selected pathogenic bacteria using a thymol-rich Thymus daenensis essential oil. J Appl Microbiol. 2017;123(4):832\u2013840.", "ArticleIdList": ["28714250"]}, {"Citation": "Van Vuuren S, Holl D. Antimicrobial natural product research: A review from a South African perspective for the years 2009-2016. J Ethnopharmacol. 2017;208:236\u2013252.", "ArticleIdList": ["28694104"]}, {"Citation": "Hufford CD, Funderburk MJ, Morgan JM, Robertson LW. Two antimicrobial alkaloids from heartwood of Liriodendron tulipifera L. J Pharm Sci. 1975;64(5):789\u2013792.", "ArticleIdList": ["807704"]}, {"Citation": "Hufford CD, Sharma AS, Oguntimein BO. Antibacterial and antifungal activity of liriodenine and related oxoaporphine alkaloids. J Pharm Sci. 1980;69(10):1180\u20131183.", "ArticleIdList": ["7420287"]}, {"Citation": "Graziose R, Rathinasabapathy T, Lategan C, Poulev A, Smith PJ, Grace M, et al. Antiplasmodial activity of aporphine alkaloids and sesquiterpene lactones from Liriodendron tulipifera. J Ethnopharmacol. 2011;133(1):26\u201330.", "ArticleIdList": ["PMC3010440", "20826204"]}, {"Citation": "Costa EV, da Cruz PE, de Louren\u00e7o CC, de Souza Moraes VR, de Lima Nogueira PC, Salvador MJ. Antioxidant and antimicrobial activities of aporphinoids and other alkaloids from the bark of Annona salzmannii A. DC. (Annonaceae) Nat Prod Res. 2013;27(11):1002\u20131006.", "ArticleIdList": ["22582985"]}, {"Citation": "De La Cruz Chac\u00f3n I, Gonz\u00e1lez-Esquinca AR. Liriodenine alkaloid in Annona diversifolia during early development. Nat Prod Res. 2012;26(1):42\u201349.", "ArticleIdList": ["21790492"]}, {"Citation": "De La Cruz Chac\u00f3n I, Gonz\u00e1lez-Esquinca AR, Feferb PG, J\u00edmenez Garcia LFJ. Liriodenine, early antimicrobial defence in Annona diversifolia. Z Naturforsch C J Biosci. 2011;66(7-8):377\u2013384.", "ArticleIdList": ["21950162"]}, {"Citation": "Clark AM, Watson ES, Asfaq MK, Hufford CD. In vivo efficacy of antifungal oxoaporphine alkaloids in experimental disseminated candidiasis. Pharm Res. 1987;4(6):495\u2013498.", "ArticleIdList": ["3508563"]}, {"Citation": "Zhang Y, Hagen F, Stielow B, Rodrigues AM, Samerpitak K, Zhou X, et al. Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports. Persoonia. 2015;35:1\u201320.", "ArticleIdList": ["PMC4713101", "26823625"]}, {"Citation": "Cisalpino PS, Puccia R, Yamauchi LM, Cano MI, da Silveira JF, Travassos LR. Cloning, characterisation, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J Biol Chem. 1996;271(8):4553\u20134560.", "ArticleIdList": ["8626811"]}, {"Citation": "Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870\u20131874.", "ArticleIdList": ["PMC8210823", "27004904"]}, {"Citation": "Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16(2):111\u2013120.", "ArticleIdList": ["7463489"]}, {"Citation": "Paula de, Silva AC, Oliveira HC, Silva JF, Sangalli-Leite F, Scorzoni L, Fusco-Almeida AM, et al. Microplate alamarBlue Assay for Paracoccidioides susceptibility testing. J Clin Microbiol. 2013;51(4):1250\u20131252.", "ArticleIdList": ["PMC3666786", "23345296"]}, {"Citation": "Arendrup MC, Meletiadis J, Mounton JW, Lagrou K, Hamal P. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeast. European Comittee on Antimicrobial Susceptibility Testing (EUCAST) 2017 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Files/EUCAST_E_Def_7_3_1_Yeast_testing__definitive.pdf"}, {"Citation": "Clinical Laboratory Standard Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. second. CLSI; Wayne, PA: 2008. Approved standard, M38- A2."}, {"Citation": "Brilhante RS, Fechine MA, Cordeiro Rde A, Rocha MF, Ribeiro JF, Monteiro AJ, et al. In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother. 2010;54(9):3978\u20133979.", "ArticleIdList": ["PMC2934947", "20566767"]}, {"Citation": "Kauffman CA. Candiduria. Clin Infect Dis. 2005;41(6):371\u2013376.", "ArticleIdList": ["16108001"]}, {"Citation": "Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis. 1999;28(2):291\u2013296.", "ArticleIdList": ["10064246"]}, {"Citation": "Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med. 2001;344(13):984\u2013996.", "ArticleIdList": ["11274626"]}, {"Citation": "Lee BE, Feinberg M, Abraham JJ, Murthy AR. Congenital malformations in a infant born to a woman treated with fluconazole. Pediatric Infect Dis J. 1992;11(12):1062\u20131064.", "ArticleIdList": ["1461702"]}, {"Citation": "Oz T, Guvenek A, Yildiz S, Karaboga E, Tamer YT, Mumcuyan N, et al. Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution. Mol Biol Evol. 2014;31(9):2387\u20132401.", "ArticleIdList": ["PMC4137714", "24962091"]}, {"Citation": "Gibbons S. Anti-staphylococcal plant natural products. Nat Prod Rep. 2004;21(2):263\u2013277.", "ArticleIdList": ["15042149"]}, {"Citation": "Lima LAR, Johann S, Cisalpino PS, Pimenta LPP. In vitro antifungal activity of fatty acid methyl ester of the seeds of Annona cornifolia A.St.-Hil (Annonaceae) against pathogenic fungus Paracoccidioides brasiliensis. Rev Soc Bras Med Trop. 2011;44(6):777\u2013780.", "ArticleIdList": ["22231254"]}, {"Citation": "Lima LARS, Alves TMA, Zani CL, Sales PA, J\u00fanior, Romanha AJ, Johann S, et al. In vitro cytotoxic, antifungal, trypanocidal and leishmanicidal activities of acetogenins isolated from Annona cornifolia A. St. -Hil. (Annonaceae) An Acad Bras Ci\u00eanc. 2014;86(2):829\u2013839.", "ArticleIdList": ["30514008"]}, {"Citation": "San-Blas G, San-Blas F, Gil F, Apitz-Castro R. Inhibition of growth of the dimorphic fungus paracoccidioides brasiliensis by ajoene. Antimicrob Agents Chemother. 1989;33(9):1641\u20131644.", "ArticleIdList": ["PMC172723", "2817865"]}, {"Citation": "Johann S, Cisalpino PS, Watanabe GA, Cota BB. Antifungal activity of extracts of some plants used in Brazilian traditional medicine against the pathogenic fungus Paracoccidioides brasiliensis. Pharma Biol. 2010;48(4):388\u2013396.", "ArticleIdList": ["20645716"]}, {"Citation": "Gullo FP, Sardi JC, Santos VA, Sangalli-Leite F, Pitangui NS, Rossi SA, et al. Antifungal activity of maytenin and pristimerin. Evid Based Complement Alternat Med. 2012;2012:340787.", "ArticleIdList": ["PMC3364566", "22675379"]}, {"Citation": "Alan\u00eds-Garza BA, Gonz\u00e1lez-Gonz\u00e1lez GM, Salazar-Aranda R, Waksman de Torres N, Rivas-Galindo VM. Screening of antifungal activity of plants from the northeast of Mexico. J Ethnopharmacol. 2007;114(3):468\u2013471.", "ArticleIdList": ["17919865"]}, {"Citation": "Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133\u2013163.", "ArticleIdList": ["PMC1797637", "17223626"]}, {"Citation": "Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin-America: a laboratory-based survey. PLoS One. 2013;8(3):e59374.", "ArticleIdList": ["PMC3601956", "23527176"]}, {"Citation": "Kaiyar SK, Edlind TD. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. Med Mycol. 2001;39(1):109\u2013116.", "ArticleIdList": ["11270397"]}, {"Citation": "Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion. J Clin Microbiol. 2010;48(4):1366\u20131377.", "ArticleIdList": ["PMC2849609", "20164282"]}, {"Citation": "Padmaja V, Thankamany V, Hara N, Fujimoto Y, Hisham A. Biological activities of Annona glabra. J Ethnopharmacol. 1995;48(1):21\u201324.", "ArticleIdList": ["8569243"]}, {"Citation": "Pinho FVS de A, da Cruz LC, Rodrigues NR, Waczuk EP, Souza CES, Coutinho HDM, et al. Phytochemical Composition, Antifungal and Antioxidant Activity of Duguetia furfuracea A. St.-Hill. Oxid Med Cell Longev. 2016;2016:7821051.", "ArticleIdList": ["PMC4835657", "27127550"]}, {"Citation": "Chastain DB, Henao-Mart\u00ednez AF, Franco-Paredes C. Opportunistic invasive mycoses in AIDS: cryptococcosis, histoplasmosis, coccidiodomycosis, and talaromycosis. Curr Infect Dis Rep. 2017;19(10):36.", "ArticleIdList": ["28831671"]}, {"Citation": "Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50(3):291\u2013322.", "ArticleIdList": ["PMC5826644", "20047480"]}, {"Citation": "Kon AS, Grumach AS, Colombo AL, Penalva ACO, Wanke B, Telles FQ, et al. Consenso em criptococose - 2008. Rev Soc Bras Med Trop. 2008;41(5):524\u2013544.", "ArticleIdList": ["19009203"]}, {"Citation": "Armstrong-James D, Brown GD, Netea MG, Zelante T, Gresnigt MS, Van de Veerdonk FL, et al. Immunotherapeutic approaches to treatment of fungal disease. Lancet Infect Dis. 2017;17(12):e393\u2013e402.", "ArticleIdList": ["28774700"]}, {"Citation": "Jarvis JN, Meintjes G, Rebe K, Williams GN, Bicanic T, Williams A, et al. Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS. 2012;26(9):1105\u20131113.", "ArticleIdList": ["PMC3640254", "22421244"]}, {"Citation": "Cardoso NN, Alviano CS, Blank AF, Romanos MT, Fonseca BB, Rozental S, et al. Synergism effect of the essential oil from Ocimum basilicum var. Maria Bonita and its major components with fluconazole and its influence on ergosterol biosynthesis. Evid Based Complement Alternat Med. 2016;2016:5647182.", "ArticleIdList": ["PMC4871963", "27274752"]}, {"Citation": "Pfaller MA, Messer SA, Boyken L, Hollis R, Rice C, Tendolkar S, et al. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis. 2004;48(3):201\u2013205.", "ArticleIdList": ["15023430"]}, {"Citation": "Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol. 2003;41(4):1440\u20131446.", "ArticleIdList": ["PMC153922", "12682127"]}, {"Citation": "Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC Infect Dis. 2005;5:99.", "ArticleIdList": ["PMC1298299", "16266438"]}, {"Citation": "Swinne D, Watelle M, Nolard N. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates. Rev Iberoam Micol. 2005;22(1):24\u201328.", "ArticleIdList": ["15813679"]}, {"Citation": "Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091\u20131100.", "ArticleIdList": ["20218877"]}, {"Citation": "Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12(3):220\u2013229.", "ArticleIdList": ["20113459"]}, {"Citation": "Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):433\u2013442.", "ArticleIdList": ["PMC4967611", "27481947"]}, {"Citation": "Verweij PE, Lestrade PP, Melchers WJ, Meis JF. Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased? J Antimicrob Chemother. 2016;71(8):2079\u20132082.", "ArticleIdList": ["27494831"]}, {"Citation": "Nabili M, Shokohi T, Moazeni M, Khodavaisy S, Aliyali M, Badiee P, et al. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue? J Med Microbiol. 2016;65(6):468\u2013475.", "ArticleIdList": ["27008655"]}, {"Citation": "Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clin Infect Dis. 2016;62(3):362\u2013368.", "ArticleIdList": ["PMC4706635", "26486705"]}, {"Citation": "Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos Trans R Soc Lond B Biol Sci. 2016;371(1709):20150460.", "ArticleIdList": ["PMC5095539", "28080986"]}, {"Citation": "Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(3):436\u2013444.", "ArticleIdList": ["28911045"]}, {"Citation": "Gon\u00e7alves SS, Souza ACR, Chowdhary A, Meis JF, Colombo AL. Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses. 2016;59(4):198\u2013219.", "ArticleIdList": ["26810669"]}, {"Citation": "Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013;9(10):e1003633.", "ArticleIdList": ["PMC3812019", "24204249"]}, {"Citation": "Snelders E, Huis In 't Veld RA, Rijs AJ, Kema GH, Melchers WJ, Verweij PE. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol. 2009;75:4053\u20134057.", "ArticleIdList": ["PMC2698372", "19376899"]}, {"Citation": "Ho Woo S, Nan-Jun Sun NJ, Cassady JM, Snapka RM. Inhibition of Topoisomerase II by Liriodenine. Biochem Pharmacol. 1997;54(4):467\u2013473.", "ArticleIdList": ["9313773"]}, {"Citation": "Jin CM, Lee JJ, Yang YJ, Kim YM, Kim YK, Ryu SY, et al. Liriodenine inhibits dopamine biosynthesis and L-DOPA-induced dopamine content in PC12 cells. Arch Pharm Res. 2007;30(8):984\u2013990.", "ArticleIdList": ["17879752"]}, {"Citation": "Tripathi SK, Xu T, Feng Q, Avula B, Shi X, Pan X, et al. Two plant-derived aporphinoid alkaloids exert their antifungal activity by disrupting mitochondrial iron-sulfur cluster biosynthesis. J Biol Chem. 2017;292(40):16578\u201316593.", "ArticleIdList": ["PMC5633121", "28821607"]}, {"Citation": "Visbal G, San-Blas G, Murgich J, Franco H. Paracoccidioides brasiliensis, paracoccidioidomycosis, and antifungal antibiotics. Curr Drug Targets Infect Dis. 2005;5(3):211\u2013226.", "ArticleIdList": ["16181141"]}, {"Citation": "San-Blas G, San-Blas F. Immune and chemical responses to paracoccidioidomycosis. In: Jacobs PH, Nall L, editors. Fungal disease: biology, immunology and diagnosis. New York: Marcel Dekker; 1997. pp. 219\u2013235."}]}], "History": [{"Year": "2020", "Month": "11", "Day": "16", "Hour": "8", "Minute": "49"}, {"Year": "2020", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "17", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["33193751", "PMC7595607", "10.1590/1678-9199-JVATITD-2020-0023"]}}]}